These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 16284537)

  • 1. Behavioral and social issues among volunteers in a preventive HIV vaccine trial in Thailand.
    Jenkins RA; Thapinta D; Morgan PA; Wongkamhaeng S; Sornsathapornkul P; Bussaratid V; Sontirat A; Pitisuttithum P; Thongchareoen P; Khamboonruang C; Suriyanon V; Nitayaphan S; Brown AE;
    J Acquir Immune Defic Syndr; 2005 Dec; 40(5):592-9. PubMed ID: 16284537
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of behavioral and social issues among Thai HIV vaccine trial volunteers.
    Thapinta D; Jenkins RA; Celentano DD; Nitayaphan S; Buapunth P; Triampon A; Morgan PA; Khamboonruang C; Suwanarach C; Yutabootr Y; Ruckphaopunt S; Suwankiti S; Tubtong V; Cheewawat W; McNeil JG; Michael RA
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Mar; 20(3):308-14. PubMed ID: 10077182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motivation, recruitment, and screening of volunteers for a phase I/II HIV preventive vaccine trial in Thailand.
    Jenkins RA; Chinaworapong S; Morgan PA; Ruangyuttikarn C; Sontirat A; Chiu J; Michael RA; Nitayaphan S; Khamboonruang C
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Jun; 18(2):171-7. PubMed ID: 9637582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Willingness to participate in AIDS vaccine trials among high-risk populations in northern Thailand.
    Celentano DD; Beyrer C; Natpratan C; Eiumtrakul S; Sussman L; Renzullo PO; Khamboonruang C; Nelson KE
    AIDS; 1995 Sep; 9(9):1079-83. PubMed ID: 8527082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preventing discrimination against volunteers in prophylactic HIV vaccine trials: lessons from a phase II trial.
    Sheon AR; Wagner L; McElrath MJ; Keefer MC; Zimmerman E; Israel H; Berger D; Fast P
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Dec; 19(5):519-26. PubMed ID: 9859967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experiences of social harm and changes in sexual practices among volunteers who had completed a phase I/II HIV vaccine trial employing HIV-1 DNA priming and HIV-1 MVA boosting in Dar es Salaam, Tanzania.
    Tarimo EA; Munseri P; Aboud S; Bakari M; Mhalu F; Sandstrom E
    PLoS One; 2014; 9(3):e90938. PubMed ID: 24603848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preventive HIV vaccine acceptability and behavioral risk compensation among high-risk men who have sex with men and transgenders in Thailand.
    Newman PA; Roungprakhon S; Tepjan S; Yim S
    Vaccine; 2010 Jan; 28(4):958-64. PubMed ID: 19925897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Willingness to participate and enroll in a phase 3 preventive HIV-1 vaccine trial.
    O'Connell JM; Hogg RS; Chan K; Strathdee SA; McLean N; Martindale SL; Willoughby B; Remis R
    J Acquir Immune Defic Syndr; 2002 Dec; 31(5):521-8. PubMed ID: 12473841
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Social and Behavioral Consequences of Participation in HIV Preventive Vaccine Trials in the ANRS COHVAC Cohort.
    Durier C; Desaint C; Launay O
    J Acquir Immune Defic Syndr; 2018 Oct; 79 Suppl 1():S37-S50. PubMed ID: 30222704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of a preventive HIV-1 vaccine cohort among persons attending sexually transmitted disease clinics in Thailand.
    Markowitz LE; Sirisopana N; Charonwatanachokchai A; Julvanichpong W; Siraprapasiri T; Palanuvej T; Siriwongrangsun P; Tungsakul V; Pumratana K; Chitwarakorn A; Michael RA; Brown AE
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Apr; 20(5):488-94. PubMed ID: 10225232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Starting from scratch: program development and lessons learned from HIV vaccine trial counseling in Thailand.
    Thapinta D; Jenkins RA
    Contemp Clin Trials; 2007 Jul; 28(4):409-22. PubMed ID: 17196444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative social impacts among volunteers in an HIV vaccine efficacy trial.
    Fuchs J; Durham M; McLellan-Lemal E; Vittinghoff E; Colfax G; Gurwith M; Buchbinder S
    J Acquir Immune Defic Syndr; 2007 Nov; 46(3):362-8. PubMed ID: 17721399
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levels of HIV risk behaviour and AIDS knowledge in Thai men having sex with men.
    Sittitrai W; Brown T; Sakondhavat C
    AIDS Care; 1993; 5(3):261-71. PubMed ID: 8218461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trial-related discrimination in HIV vaccine clinical trials.
    Allen M; Israel H; Rybczyk K; Pugliese MA; Loughran K; Wagner L; Erb S
    AIDS Res Hum Retroviruses; 2001 May; 17(8):667-74. PubMed ID: 11429107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knowledge, attitudes and behaviour among HIV-positive and HIV-negative clients of a confidential HIV counselling and testing centre in Thailand.
    Phanuphak P; Müller O; Sarangbin S; Sittitrai W
    AIDS; 1994 Sep; 8(9):1315-9. PubMed ID: 7802986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk behavior for HIV infection in participants in preventive HIV vaccine trials: a cautionary note.
    Chesney MA; Chambers DB; Kahn JO
    J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Dec; 16(4):266-71. PubMed ID: 9402073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Issues in women's participation in a phase III community HIV vaccine trial in Thailand.
    Kaewkungwal J; Pitisuttithum P; Rerks-Ngarm S; Nitayaphan S; Khamboonruang C; Kunasol P; Suntharasamai P; Pungpak S; Vanijanonta S; Bussaratid V; Maek-A-Nantawat W; Dhitavat J; Thongcharoen P; Pawarana R; Sabmee Y; Benenson MW; Morgan P; O'Connell RJ; Kim J
    AIDS Res Hum Retroviruses; 2013 Nov; 29(11):1524-34. PubMed ID: 23343395
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anticipated changes in sexual risk behaviour following vaccination with a low-efficacy HIV vaccine: survey results from a South African township.
    Andersson KM; Vardas E; Niccolai LM; Van Niekerk RM; Mogale MM; Holdsworth IM; Bogoshi M; McIntyre JA; Gray GE
    Int J STD AIDS; 2012 Oct; 23(10):736-41. PubMed ID: 23104749
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International clinical trials of HIV vaccines: I. Phase I trial of an HIV-1 synthetic peptide vaccine in Bangkok, Thailand.
    Phanuphak P; Teeratakulpixarn S; Sarangbin S; Nookhai S; Ubolyam S; Sirivichayakul S; Leesavan A; Forrest BD; Hanson CV; Li M; Wang CY; Koff WC
    Asian Pac J Allergy Immunol; 1997 Mar; 15(1):41-8. PubMed ID: 9251847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk behaviours and comprehension among intravenous drug users volunteered for HIV vaccine trial.
    Pitisuttithum P; Migasena S; Laothai A; Suntharasamai P; Kumpong C; Vanichseni S
    J Med Assoc Thai; 1997 Jan; 80(1):47-50. PubMed ID: 9078816
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.